The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis

NCT01451489 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

70

Enrollment

OTHER

Sponsor class

Stopped The recruitment of subject is very difficult

Conditions

FSGS

Interventions

DRUG: FK506
DRUG: Cyclophosphamide

Sponsor

Nanjing University School of Medicine